JUSTINE KATINDOY: Open Payments
NPI 1760970784 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$138 in 5 payments from 5 companies in 2025. Trend: 2023 $1,155 · 2024 $781 · 2025 $138
Food & beverage: $138
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 1 | $38 |
| Alnylam Pharmaceuticals Inc. | 1 | $33 |
| GlaxoSmithKline, LLC. | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
Products named: GIVLAARI, BLENREP, CALQUENCE, Tazverik.
Industry payments across CA — which companies pay providers there.
